These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20848555)

  • 21. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy.
    Desir J; Moya G; Reish O; Van Regemorter N; Deconinck H; David KL; Meire FM; Abramowicz MJ
    J Med Genet; 2007 May; 44(5):322-6. PubMed ID: 17220209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4.
    Riazuddin SA; Vasanth S; Katsanis N; Gottsch JD
    Am J Hum Genet; 2013 Oct; 93(4):758-64. PubMed ID: 24094747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies.
    Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR
    Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the genetics of corneal endothelial dystrophies.
    Kannabiran C; Chaurasia S; Ramappa M; Mootha VV
    Indian J Ophthalmol; 2022 Jul; 70(7):2239-2248. PubMed ID: 35791103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional ion transport properties of human SLC4A11: comparison of the SLC4A11-B and SLC4A11-C variants.
    Kao L; Azimov R; Shao XM; Frausto RF; Abuladze N; Newman D; Aldave AJ; Kurtz I
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C820-C830. PubMed ID: 27581649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies.
    Loganathan SK; Schneider HP; Morgan PE; Deitmer JW; Casey JR
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C735-C748. PubMed ID: 27558157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11.
    Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective cell adhesion function of solute transporter, SLC4A11, in endothelial corneal dystrophies.
    Malhotra D; Jung M; Fecher-Trost C; Lovatt M; Peh GSL; Noskov S; Mehta JS; Zimmermann R; Casey JR
    Hum Mol Genet; 2020 Jan; 29(1):97-116. PubMed ID: 31691803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy.
    Patel SP; Parker MD
    Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ZEB1 and TCF4 rs613872 changes with late onset Fuchs endothelial corneal dystrophy in patients from northern India.
    Gupta R; Kumawat BL; Paliwal P; Tandon R; Sharma N; Sen S; Kashyap S; Nag TC; Vajpayee RB; Sharma A
    Mol Vis; 2015; 21():1252-60. PubMed ID: 26622166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R125H, W240S, C386R, and V507I SLC4A11 mutations associated with corneal endothelial dystrophy affect the transporter function but not trafficking in PS120 cells.
    Li S; Hundal KS; Chen X; Choi M; Ogando DG; Obukhov AG; Bonanno JA
    Exp Eye Res; 2019 Mar; 180():86-91. PubMed ID: 30557570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal dystrophy-causing SLC4A11 mutants: suitability for folding-correction therapy.
    Loganathan SK; Casey JR
    Hum Mutat; 2014 Sep; 35(9):1082-91. PubMed ID: 24916015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel mutations including a large deletion of the SLC4A11 gene causing autosomal recessive hereditary endothelial dystrophy.
    Puangsricharern V; Yeetong P; Charumalai C; Suphapeetiporn K; Shotelersuk V
    Br J Ophthalmol; 2014 Oct; 98(10):1460-2. PubMed ID: 25138764
    [No Abstract]   [Full Text] [Related]  

  • 34. Loss of ion transporters and increased unfolded protein response in Fuchs' dystrophy.
    Jalimarada SS; Ogando DG; Bonanno JA
    Mol Vis; 2014; 20():1668-79. PubMed ID: 25548511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy.
    Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M
    Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress.
    Guha S; Chaurasia S; Ramachandran C; Roy S
    Sci Rep; 2017 Jun; 7(1):4074. PubMed ID: 28642546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Corneal Expression of SLC4A11, a Gene Mutated in Endothelial Corneal Dystrophies.
    Malhotra D; Loganathan SK; Chiu AM; Lukowski CM; Casey JR
    Sci Rep; 2019 Jul; 9(1):9681. PubMed ID: 31273259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.
    Biswas S; Munier FL; Yardley J; Hart-Holden N; Perveen R; Cousin P; Sutphin JE; Noble B; Batterbury M; Kielty C; Hackett A; Bonshek R; Ridgway A; McLeod D; Sheffield VC; Stone EM; Schorderet DF; Black GC
    Hum Mol Genet; 2001 Oct; 10(21):2415-23. PubMed ID: 11689488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic screen of African Americans with Fuchs endothelial corneal dystrophy.
    Minear MA; Li YJ; Rimmler J; Balajonda E; Watson S; Allingham RR; Hauser MA; Klintworth GK; Afshari NA; Gregory SG
    Mol Vis; 2013; 19():2508-16. PubMed ID: 24348007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harboyan syndrome: novel SLC4A11 mutation, clinical manifestations, and outcome of corneal transplantation.
    Tananuvat N; Tananuvat R; Chartapisak W; Mahanupab P; Hokierti C; Srikummool M; Kampuansai J; Intachai W; Olsen B; Ketudat Cairns JR; Kantaputra P
    J Hum Genet; 2021 Feb; 66(2):193-203. PubMed ID: 32884076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.